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Abstract 
 
Metastasis is the main cause of death among brast cancer patient. Pleorotus ostreatus is 
known as anticancer agent that inhibits angiogenesis. Ethanolic extract of Pleorotus ostreatus 
(EEP) which contains lovastatin is predicted to inhibit metastatic cancer through inhibition of 
MMP-2 and MMP-9. The aim of this study was to determined antiproliferative and anti 
metastatic activity of EEPw (Ethanolic extract of wet Pleorotus ostreatus) and EEPd (Ethanolic 
extract of dried Pleorotus ostreatus) in 4T1 metastatic breast cancer cells line. Qualitative 
analysis of lovastatin was determined by thin layer chromatography (TLC) using 
dicloromethan and etil acetat as mobile phase and lovastatin standard. Scratch wound healing 
assay was used to determine migration inhition ability of EEP while MMP-9 and MMP-2 
activity were analysed by gelatine zymography. Molecular docking was performed to know 
the interaction between lovastatin and MMP-2 & MMP-9. The result showed that EEPw and 
EEPd contain lovastatin which were proved by spray reaction with anisaldehid. Each of EEPw 
and EPPd had cytotoxic activity with IC50 760 and 400 μg/mL respectively. Both of them 
inhibited closure for about 50 % on 4T1 metastatic breast cancer cells line compared to 
control. Either EEPw or EEPd decreased MMP-9 expression level compared to control. 
Lovastatin had higher affinity to bond with either MMP-2 or MMP-9 than native ligand. 
Overall, EEP could be developed as anticancer agent which was targeted on MMP-2 and 
MMP-9. 
 
Keywords : Pleurotus ostreatus, 4T1 metastatic cells, MMP-2, MMP-2, antimetastatic 
 
 
INTRODUCTION 
 
In 2014, 21.4% of deaths among women 
was due to breast cancer (WHO, 2014), 
especially after the occurrence of metastasis. 
Metastasis is a complex molecular process 
which cancer cells leave the first place to grow 
towards other organs and proliferate to form a 
new tumor mass (Brooks, et al., 2010). 
Metastasis activity was due to the activity of 
metalloproteinases (MMPs), especially MMP-2 
and MMP-9 which degraded collagenase VI 
(gelatin) in cancer cells (Liotta, 1991, Stetler-
Stevenson, 1994). Nowdays, treatment of 
metastatic cancer is targeted to the activity of 
MMP-2 and MMP-9. Effective and efficient 
treatment can be done by utilizing potential 
compounds from natural materials such as 
oyster mushroom (Pleurotus ostreatus). 
P.ostreatus is an edible mushroom that 
contains lovastatin (Lakshmanan and Radha, 
2013). Lovastatin could decreased angiogenesis 
by inhibit VEGF activity (Zhao, et al., 2010; 
Xiao, et al., 2012). Angiogenesis triggered 
cancer cell metastasis (Rivilis, et al., 2002). 
Therefore, lovastatin activity as inhibitors of 
VEGF could inhibit MMP-2 and MMP-9 
activity to prevent metastasis. 
 This study aims to determined the 
ability of P.ostreatus extract to inhibit cancer 
cells proliferation and metastasis. The study 
was conducted by observing cell migration by 
scratch wound healing assay and protein 
activity of MMP-2 and MMP-9 by gelatin 
zymography. At the molecular level, molecular 
docking was performed between lovastatin and 
target protein MMP-2 and MMP-9.  
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MATERIALS AND METHODS 
 
Sample 
The P.ostreatus were collected from 
Sleman, Yogyakarta and determined by 
Biological Pharmacy Labroratorium, Faculty of 
Pharmacy Universitas Gadjah Mada. 
P.ostreatus were extracted in ethanol 96% for 
72 h, then the mixture was filtered to remove 
the marc. The extract was concentrated using 
rotary evaporator. Sample was dissolved in 
dimethyl Sulfoxide (DMSO) (Sigma). Both of 
EEPd and EEPw were diluted in cell culture 
medium before being applied. DMSO was used 
as the co-solvent to dissolved samples in 
culture medium. 
 
Cell Culture 
4T1 cells were obtained from Cancer 
Cancer Chemoprevention Research Center, 
Yogyakarta. The cells were maintained in 
DMEM (Gibco) supplemented with 10 % Fetal 
Bovine Serum (FBS) (Sigma), 1.5% Penicillin-
Streptomycin, and 0.5% fungizone at 37
o
C in 
humidified atmosphere of 5 % CO2. Trypsin-
EDTA 0.25% (Gibco) was used in cell 
subculture.  
  
Cell Viability Assay 
Cell viability was determined using MTT 
assay. Cells were seeded into a 96-well plate 
(8000 cells per well) and incubated for 24 h. 
Cells were treated with various concentration of 
EEPd and EEPw. Certain concentration of 
either single or combination of samples were 
the applied. After 48 h incubation, MTT reagent 
[3-(4,5-dimethyl-2.thiazolyl)-2,5-
diphenyltetrazolium bromide in PBS 
(5mg/mL)] was added to each well. The plate 
was incubated in a humidified atmosphere of 
5% CO2 at 37
o
C for 3 h, formazan crystals were 
dissolved in 10% SDS and incubated overnight. 
The absorbance of cells was measured at 595 
nm by a microplate reader. The data was 
presented as percentage of viable cells (%).  
 
Scratch Wound Healing Assay  
Cells (5x10
4
 cells/well) were seeded on 
24 well plates until 80% confluent. Cells were 
scartched using microtip. Cells were incubated 
24 h hour, then replaced with fresh medium 
contain EEPw and EEPd. After that incubated 
in 37
o
C for 48 h, cells were observed in 0 h, 18 
h, 24 h, and 42 h under the microscope.  
 
Gelatin-Zymograph Methods 
 Gel of 20% acrylamid-bis acrylamid 
containing 1% gelatin was made in the buffer. 
Cells were washed by PBS and then incubated 
in 37°C for 24 h. Medium was collected and 
centrifuged at 400 g for 5 min, 4°C and 
supernatant was collected. Cells were washed 
with cold PBS then added with 2 ml cold lysis 
buffer.  
 Cells was harvested with a scrapper to 
collect lysate and incubated on ice for 15 
minutes. Lysate then centrifuged for 16000 g 
for 2 min at 4°C and supernatant was collected. 
Mix 75 mL of the supernatant with 25 mL of 
sample buffer (4x). 30 mL of sample was put 
into sinks. Electrophoresis was performed with 
the condition of 125 V, 30-40 mA for 90 
minutes. The Gel then soaked in coomasie blue 
dye solution for 1 hour to form a transparent 
band with a dark blue background. 
 
Molecular Docking 
In silico study by molecular docking was 
conducted to examine the affinity of ligand to 
its docking site by evaluating drug-receptor 
binding energy. Evaluation of the interaction 
between a molecule and its docking protein 
involved in particular signal transduction may 
represent its potential biological activity and 
allow us to determine the possible mechanism 
of action. In this study, the docking of 
lovastatin in Ligan native. Ligand preparation 
was done by using Marvin Sketch. Protein 
preparation was done by using YASARA. 
Molecular docking was conducted by using 
PLANTS (Protein-Ligand Ant System) 
Software, giving ∆G as docking score result. 
 
RESULTS 
 
EEPw and EEPd Showed Cytotoxic 
Activity on 4T1 Cells 
Cell viability assay was done to 
determine the inhibitory concentration (IC50) of 
EEPw and EEPd, on 4T1cells (Fig. 1). All of 
these compounds shows cytotoxic effect in dose 
dependent manner. EEPw and EEPd had the 
IC50 values of 760 μg/mL and 400 μg/mL, 
respectively.
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Figure 1.  Cell viability assay of (a) EEPw (b) EEPd in 4T1 cells. Cells were incubated for 24 h then add 
with MTT and incubated overnight then read the absorbance using ELISA reader. Result showed that 
EEPd and EEPw had the IC50 values 400 μg/mL (a) and 760 μg/mL (b). 
 
 
Scratch Wound Healing Assay 
The scratch assay was done to explored 
EEPw and EEPd effect in migration breast 
cancer cell 4T1 (Fig.2 and 3). 4T1 cell was used 
as model in scratch assay due to its ability to 
performed metastasis. 
 EEPw and EEPd had the abilit to 
lowering the closure area on 4T1 breast 
metastatic cells compared to control cells. 
 
Molecular docking 
In silico test by molecular docking was 
done to predict the ability of oleandrin and 
synamaldehid to interacting with MMP-2 and 
MMP-9 receptor. That interaction is visualized 
and determinated by amino acid residue which 
interacting between oleandrin and 
cynamaldehid ligand against MMP-2 and 
MMP-9 (Table 1). 
 
 
 
Figure 2. Effect of EEPd and EEPw against % closure. Observation area closure was performed using Image-J 
program to calculate the area of a scratch on 0h , 18h, 24h and 42h with a concentration EEPw or EEPd ¼ 
and 1/8 then expressed as % closure. 
 
 
Gelatin Zymograph assay 
 
Figure 3. Effect EEPw and EEPd to % the intensity of the band 
EEPw (μg/mL) 
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Table  1. Molecular Docking Score 
 MMP-2 MMP-9 
RMSD  2,375°A    1,8338 °A 
Lovastatin 
Ligan Native 
-111                 -94 
-124               -136 
 
 
 
DISCUSSION 
 
 Overexpression of the protein MMP-2 
and MMP-9 is one factor leading to breast 
cancer cell metastasis (Liotta, 1991). The 
results showed that EEPw and EEPd were 
cytotoxic against 4T1 breast cancer cells with 
IC50 of 760 μg/mL and 400 μg/mL respectively. 
EEP has intermediate potency as cytotoxic 
agent. 
 Inhibition of the closure area show the 
ability of EEP to reduce breast cancer cell 
migration. Results of the study showed that 
EEPw and EEPd with the smallest 
concentration of IC50 could of decreased % 
closures compared to control cells.  
 MMP-9 is an MMP family members that 
have been known to have a role in the invasion 
and metastasis of cancer cells. MMP-9 are 
classified into type IV collagenase is based on 
its ability to hydrolyze IV collagen (gelatine) 
(Wilhelm, et al., 1989). Results of the test using 
the gelatin zymograph showed a decrease in 
activity of MMP-9. EEPd and EEPw reduce the 
expression of MMP-9 protein in compare to 
control based on the intensity of the band. 
 Based on molecular docking, lovastatin 
could to compete with native ligand to interact 
with MMP-2 and MMP-9 as being shown 
through the same amino acid residue that 
interacted with protein MMP-2 and MMP-9. 
Therefore, bond between lovastatin with MMP-
2 and MMP-9 can reduce the chances of 
continuous proliferation through inhibition of 
protein expression of MMP-2 and MMP-9. 
These results indicate that EEP inhibit 
expression of MMP-2 and MMP-9 protein. 
Hence, proliferation of 4T1 breast cancer cells 
could be inhibited. 
 
CONCLUSION 
 
 The results showed that EEP reduce 
viability of 4T1 breast cancer cells and inhibits 
cell migration and protein expression of MMP-
2 and MMP-9. 
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